Mass vaccination, immunity and coverage: Modelling population protection against foot-and-mouth disease in Turkish cattle

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Knight Jones, T J D ^a,b   Gubbins, S ^a   Bulut, A N ^c   Stark K D C ^b   Pfeiffer, D U ^b   Sumption, K J ^d   Paton, D J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c SAP Institute   (Turkey)

^d FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; BLOOD; BOVINE; CATTLE DISEASES; FOOT AND MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; MASS IMMUNIZATION; PROCEDURES; THEORETICAL MODEL; TURKEY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MASS VACCINATION; MODELS, THEORETICAL; TURKEY; VIRAL VACCINES;

EID: 84959304607     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22121     Document Type: Article

References (48)

1. Knight-Jones, T. J. D. & Rushton, J. The economic impacts of foot and mouth disease-what are they, how big are they and where do they occur? Prev Vet Med 112, 161-173, doi: 10.1016/j.prevetmed.2013.07.013 (2013).
2. Knight-Jones, T. J. D., Edmond, K., Gubbins, S. & Paton, D. J. Veterinary and human vaccine evaluation methods. Proc Biol Sci 281, 20132839, doi: 10.1098/rspb.2013.2839 (2014).
3. Terpstra, C., Van Maanen, C. & Van Bekkum, J. G. Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations. Res Vet Sci 49, 236-242 (1990).
4. Cox, S. J. et al. Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve. Vaccine 28, 2318-2322, doi: 10.1016/j.vaccine.2009.12.065 (2010).
5. Doel, T. R. FMD vaccines. Virus Res 91, 81-99 (2003).
6. Brehm, K. E., Kumar, N., Thulke, H. H. & Haas, B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26, 1681-1687, doi: 10.1016/j.vaccine.2008.01.038 (2008).
7. Pay, T. W. F. Factors influencing the performance of foot-and-mouth disease vaccines under field conditions In. Applied virology, (ed Kurstak, E.) 73-86 (Academic Press Inc. Orlando, USA & London, 1984).
8. Knight-Jones, T. J. D. et al. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey. Vaccine 33, 805-811, doi: 10.1016/j.vaccine.2014.12.010 (2015).
9. Doel, T. R. Natural and vaccine induced immunity to FMD. Curr Top Microbiol 288, 103-131 (2005).
10. Späth, E. J. et al. Immune response of calves to foot-and-mouth disease virus vaccine emulsified with oil adjuvant. Strategies of vaccination. Vaccine 13, 909-914, doi: 10.1016/0264-410X(95)00009-P (1995).
11. Turkish Statistical Institute. Animal Production Statistics, 2012-http://www.turkstat.gov.tr/PreHaberBultenleri.do?id=13512. (2013) (Date of access: 01/11/2013).
12. Askaroglu, H. EU project for the control of FMD in Turkey, West Eurasia Roadmap FMD Control 2010-2020, 7-9 October, 2009 - Istanbul, Turkey. (2009).
13. Knight-Jones, T. J. D. et al. Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey. Vaccine 32, 1848-1855, doi: 10.1016/j.vaccine.2014.01.071 (2014).
14. Reeve, R. et al. Reducing animal experimentation in foot-and-mouth disease vaccine potency tests. Vaccine 29, 5467-5473, doi: 10.1016/j.vaccine.2011.05.056 (2011).
15. Barnett, P. V., Statham, R. J., Vosloo, W. & Haydon, D. T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21, 3240-3248, doi: 10.1016/s0264-410x(03)00219-6 (2003).
16. Van Bekkum, J. G., Fish, R. C. & Nathans, I. Immunologic responses in dutch cattle vaccinated with foot-and-mouth disease vaccines under field conditions: Neutrailizing antibody responses and immunity to O, A and C types. Am J Vet Res 30, 2125-2129 (1969).
17. Pay, T. W. F. & Hingley, P. J. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle. Dev Biol Stand 64, 153-161 (1986).
18. Van Maanen, C. & Terpstra, C. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Virol Methods 124, 111-119 (1989).
19. Gelman, A. & Hill, J. Data analysis using regression and multilevel/hierarchical models. Pp 150-1, (Cambridge University Press, 2007).
20. Smitsaart, E. N. et al. Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines. Prev Vet Med 33, 283-296 (1998).
21. Robiolo, B. et al. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 28, 6235-6241, doi: 10.1016/j.vaccine.2010.07.012 (2010).
22. Robiolo, B. et al. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine 24, 997-1008, doi: 10.1016/j.vaccine.2005.08.071 (2006).
23. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. (2014) (Date or access: 25/11/2015).
24. Barasa, M. et al. Foot-and-Mouth Disease Vaccination in South Sudan: Benefit-Cost Analysis and Livelihoods Impact. Transbound Emerg Dis 55, 339-351, doi: 10.1111/j.1865-1682.2008.01042.x (2008).
25. Forman, S. et al. Moving towards the global control of foot and mouth disease: an opportunity for donors. Rev Sci Tech 28, 883-896 (2009).
26. Sutmoller, P., Barteling, S. S., Olascoaga, R. C. & Sumption, K. J. Control and eradication of foot-and-mouth disease. Virus Res 91, 101-144 (2003).
27. Selman, P., Chénard, G. & Dekker, A. Cedivac-FMD; Duration of Immunity in cattle, sheep and pigs. Open session of the EuFMD, Paphos, Cyprus, 17-19 October 2006 http://www.fao.org/ag/againfo/commissions/docs/research-group/paphos/App31.pdf. (2006) (Date of access: 21/02/2014).
28. Bulut, A. N. FMD situation in Turkey presented at 6th West Eurasia Roadmap Meeting, Almaty, Kazakhstan, 28-30 April 2015 http://www.fao.org/fileadmin/user-upload/eufmd/Roadmap-2015/TurkeyCountryReport.pdf. (2015) (Date of access: 25/11/2015).
29. Bulut, A. N. FMD situation in Turkey-5th West Eurasia roadmap meeting. Astana, Kazakhstan 23-24 April 2014. (2014).
30. Bulut, A. N. FMD situation in Turkey. West EurAsia FMD Control-Roadmap 2025, 4th Annual Regional Progress Review Meeting, 2-4th April 2013, Baku, Azerbaijan. (2013).
31. EC-ADNS. Animal disease notification system: outbreaks per disease ADNS disease overview report 1st Jan-31st Dec 2015 http://ec.europa.eu/food/animal/diseases/adns/table-11-2015.pdf. (2015) (Date of access: 07/01/2016).
32. ProMED. Foot and mouth disease-Turkey (06): serotype A, topotype asia, Genotype VII, spread, endemic, oie, request for information. Report Wed 16 Dec 2015 Archive Number: 20151218.3872002 http://www.promedmail.org/post/3872002. (2015) (Date of access: 07/01/2016).
33. The Pirbright Institute & The Sap Institute. WRLFMD-Joint Genotyping Report with the Sap Institute. Turkey FMDV type A 10 November 2015 http://www.wrlfmd.org/fmd-genotyping/2015/WRLMEG-2015-00019%20A%20Turkey%202015%20v2.pdf. (2015) (Date of access: 07/01/2016).
34. Knight-Jones, T. J. D. PhD Thesis-Field evaluation of foot-and-mouth disease vaccination in Turkey. The Pirbright Institute & The Royal Veterinary College, University of London. https://www.researchgate.net/publication/271498205-Field-evaluation-of-footand-mouth-disease-vaccination-in-Turkey, (2014) (Date of access: 25/11/2015).
35. Metwally, S. et al. OIE-FAO Foot and mouth disease post-vaccination monitoring guidelines. (In press).
36. Robiolo, B. et al. Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle. J Virol Methods 166, 21-27, doi: 10.1016/j. jviromet.2010.02.011 (2010).
37. León, E. A. et al. Effectiveness of systematic foot and mouth disease mass vaccination campaigns in Argentina Rev Sci Tech 33, 917-926 (2014).
38. Arrowsmith, A. E. Variation among strains of type A foot-and-mouth disease virus in the Eastern Mediterranean region 1964-1972. J Hyg (Lond) 75, 387-397 (1975).
39. Knowles, N. J. et al. Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle East. Transbound Emerg Dis 56, 157-169, doi: 10.1111/j.1865-1682.2009.01074.x (2009).
40. Maradei, E. et al. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine 26, 6577-6586, doi: 10.1016/j.vaccine.2008.09.033 (2008).
41. Robinson, L. & Knight-Jones, T. J. D. Global FMD Research Alliance/EuFMD-Global foot-and-mouth disease research update and gap analysis 2014-Vaccines chapter http://go.usa.gov/cZgG9. (2014) (Date of access: 25/01/2016).
42. Dekker, A. & Terpstra, C. Prevalence of foot-and-mouth disease antibodies in dairy herds in The Netherlands four years after vaccination. Res Vet Sci 61, 89-91 (1996).
43. Remond, M., Kaiser, C., Lebreton, F. O., Moutou, F. & Cruciere, C. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban. Vet Res 32, 81-86, doi: 10.1051/vetres:2001112 (2001).
44. McLaws, M. Monitoring FMD occurance-EuFMD Open session, 29-31 Oct 2012, Jerez, Spain (2012).
45. Naranjo, J. & Cosivi, O. Elimination of foot-and-mouth disease in South America: lessons and challenges. Philos Trans R Soc Lond B Biol Sci 368, 20120381, doi: 1098/rstb.2012.0381 (2013).
46. Leforban, Y. & Gerbier, G. Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia. Rev Sci Tech 21, 477-492 (2002).
47. Knight-Jones, T. J. D. & Rushton, J. Foot-and-mouth disease impact on smallholders-What do we know, what don't we know and how can we find out more? Transbound Emerg Dis In press (2016).
48. Woolhouse, M. E. J., Haydon, D. T., Pearson, A. & Kitching, R. P. P. Failure of vaccination to prevent outbreaks of foot and mouth disease. Epidemiol Infect 116, 363-371 (1996).